A large scale high throughput screen identifies chemical inhibitors of phosphatidylinositol 4-kinase type II alpha.

Therapeutic Approaches


The minor phospholipid, phosphatidylinositol 4-phosphate (PI4P) is emerging as a key regulator of lipid transfer in ER-membrane contact sites. Four different phosphatidylinositol 4-kinase (PI4K) enzymes generate PI4P in different membrane compartments supporting distinct cellular processes, many of which are crucial for the maintenance of cellular integrity but also hijacked by intracellular pathogens. While type III PI4Ks have been targeted by small molecular inhibitors, thus helping decipher their importance in cellular physiology, no inhibitors are available for the type II PI4Ks, which hinders investigations into their cellular functions. Here we describe the identification of small molecular inhibitors of PI4K2A by implementing a large scale small molecule high throughput screening. A novel assay was developed that allows testing of selected inhibitors against PI4K2A in intact cells using a BRET approach adapted to plate readers. The compounds disclosed here will pave the way to the optimization of PI4K2A inhibitors that can be used in cellular and animal studies to better understand the role of this enzyme in both normal and pathological states.


Sengupta, Nivedita; Jović, Marko; Barnaeva, Elena; Kim, David; Hu, Xin; Southall, Noel; Dejmek, Milan; Mejdrova, Ivana; Nencka, Radim; Baumlova, Adriana; Chalupska, Dominika; Boura, Evzen; Ferrer-Alegre, Marc; Marugan, Juan; Balla, Tamas;

External Links